First Time Loading...

Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 512.5 JPY 1.41% Market Closed
Updated: Apr 30, 2024

Santen Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Revenue
¥302.1B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Revenue
¥4.2T
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Revenue
¥1.5T
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
4%
Otsuka Holdings Co Ltd
TSE:4578
Revenue
¥2T
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Revenue
¥1.1T
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
10%
Astellas Pharma Inc
TSE:4503
Revenue
¥1.9T
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%

See Also

What is Santen Pharmaceutical Co Ltd's Revenue?
Revenue
302.1B JPY

Based on the financial report for Dec 31, 2023, Santen Pharmaceutical Co Ltd's Revenue amounts to 302.1B JPY.

What is Santen Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Santen Pharmaceutical Co Ltd have been 8% over the past three years , 6% over the past five years , and 8% over the past ten years .